Dr. Anna Tarakanova's research focuses on understanding the structure and mechanics of elastin, a protein that allows arteries to stretch and recoil, providing efficient blood circulation. By investigating how aging and disease impact elastin's properties, her lab aims to develop new strategies for preventing and treating cardiovascular issues. The research combines advanced modeling techniques and experimental approaches to uncover the connections between molecular structure and function in arterial tissues.

Dr. Changchun Liu's research lab focuses on developing innovative methods for HIV viral load testing using CRISPR technology. The lab aims to create a rapid and cost-effective diagnostic tool that can be used in resource-limited settings, addressing the urgent need for accessible HIV testing. This work combines advanced biomedical engineering techniques with molecular biology to improve public health outcomes related to HIV/AIDS.

Dr. Yi Zhang's lab at the University of Connecticut Storrs focuses on improving our understanding of mental disorders through advanced neurochemical monitoring techniques. By developing a wireless neural probe that can sample multiple neuropeptides and conduct pharmacological stimulation in freely moving animals, the lab aims to uncover the molecular mechanisms that drive various behavioral outputs in the brain. This innovative approach seeks to enhance the precision of neurochemical measurements in real-time, potentially leading to better treatment strategies for mental health conditions.

Dr. Hugo Fernando Posada-Quintero's lab focuses on developing advanced methods to objectively measure visceral pain, particularly in patients suffering from Irritable Bowel Syndrome (IBS). The team aims to create a novel biomarker that combines data from various physiological measurements to aid in pain management and enhance treatment outcomes. This research is significant as it can lead to new non-drug therapies for managing IBS-related pain, improving the quality of life for many patients.